Vincristine Drug Shortage Stirs Concern for Impact on Pediatric Patients with Cancer
A shortage of vincristine, a vital chemotherapy agent used to treat several pediatric cancers, has health care providers concerned about the potential implications for vulnerable patient populations.
According to The New York Times, which first reported on the shortage, physicians shared concerns that dwindling supplies of the essential drug may lead to the need to ration doses for their patients.
